Entera Bio Ltd. (ENTX) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$7.37M | -8.1% |
| 2024 | -$6.82M | +6.7% |
| 2023 | -$7.31M | +41.5% |
| 2022 | -$12.50M | -37.9% |
| 2021 | -$9.06M | +14.2% |
| 2020 | -$10.56M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$7.37M | -8.1% |
| 2024 | -$6.82M | +6.7% |
| 2023 | -$7.31M | +41.5% |
| 2022 | -$12.50M | -37.9% |
| 2021 | -$9.06M | +14.2% |
| 2020 | -$10.56M | — |